TDP2 and cancer: Our findings support this hypothesis, as TDP2 KD cancer cells exhibited reduced cell proliferation, disturbed cell cycle profiles, and increased sensitivity to ACP52C compared to mock cells (Figure S16B–E, Supporting Information).